Home › Connective Tissue Disorders › North Carolina › Durham
Connective Tissue Disorders clinical trials in Durham, NC
5 studies for Connective Tissue Disorders are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecruitingPhase 3
- GSK Investigational Site, Durham
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
RecruitingPhase 3
- Duke Orthopaedic Surgery, Durham
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
- Duke University, Durham
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 2
- Duke University Medical Center, Durham
About Connective Tissue Disorders
There are over 200 disorders that affect connective tissues. Examples include cellulitis, scars, and osteogenesis imperfecta. Learn more.
More about Connective Tissue Disorders on MedlinePlus
Connective Tissue Disorders trials in other cities
- New York City, NY4 studies
- Boston, MA3 studies
- Houston, TX3 studies
- Los Angeles, CA3 studies
- Philadelphia, PA3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.